Skip to main content
GutCited

Vitamin D 관련 Inflammatory Bowel Disease (IBD) — General

B

Supplementation (1,000-4,000 IU/day) reduces relapse risk in both UC and Crohn's. Deficiency is common in IBD (up to 60%) and correlates with disease severity.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dinflammatory\u002Dbowel\u002Ddisease'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

결론

Supplementation (1,000-4,000 IU/day) reduces relapse risk in both UC and Crohn's. Deficiency is common in IBD (up to 60%) and correlates with disease severity.

Key Study Findings

Review
Early Evidence Indicates Vitamin D Improves Symptoms of Irritable Bowel Syndrome: Nursing Implications and Future …
Dose: None vs: None Outcome: IBS symptom improvement with vitamin D supplementation 효과: None None

대상 집단: individuals with irritable bowel syndrome

Review
Diet in Ulcerative Colitis: A Narrative Review of Its Role in Pathogenesis and Treatment.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: patients with ulcerative colitis

Review
Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: review of probiotics as therapeutic strategy for inflammatory bowel disease

Review
Micronutrient Deficiencies in Pediatric IBD: How Often, Why, and What to Do?
Dose: None vs: None Outcome: Micronutrient deficiency management in pediatric IBD 효과: None None

대상 집단: Children with inflammatory bowel disease (review)

Observational Study n=193
The importance of vitamin D levels in patients with inflammatory bowel disease.
Dose: None vs: Clinical activity groups and VD status groups Outcome: Vitamin D levels and IBD activity markers 효과: None 0.009 (CD), 0.033 (UC), 0.032

대상 집단: Greek IBD patients (122 CD, 71 UC)

Review
Osteoporosis: A Review.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: Adults with osteoporosis

Key Statistics

10

연구

1500

참여자

Positive

B

등급

Referenced Papers

JAMA 2025
Swiss medical weekly 2024 9 인용
Paediatrics and international … 2023 48 인용
Archives of Iranian … 2023 2 인용
The Cochrane database … 2023 1 인용
Endocrine connections 2022 50 인용
Journal of inflammation … 2022 50 인용
Frontiers in bioscience … 2022 17 인용
European journal of … 2021 40 인용
Autoimmunity reviews 2020 48 인용
Acta biochimica Polonica 2020 10 인용
The Korean journal … 2020 3 인용
Revista espanola de … 2020 2 인용
Frontline gastroenterology 2019 58 인용
Critical reviews in … 2019 45 인용
Current opinion in … 2019 5 인용
Gastroenterology clinics of … 2018 67 인용
Journal of research … 2018 48 인용
Nutrition in clinical … 2017 55 인용
World journal of … 2016 238 인용
Current gastroenterology reports 2016 22 인용
Journal of medicinal … 2016 17 인용
Gastroenterology & hepatology 2016 7 인용
BioMed research international 2015 149 인용
World journal of … 2015 62 인용
Healthcare (Basel, Switzerland) 2015 7 인용
Journal of inflammation … 2014 411 인용
Inflammatory bowel diseases 2012 224 인용
Vitamins and hormones 2011 25 인용
Joint bone spine 2010 281 인용
Acta medica Indonesiana 2007 4 인용
Nature clinical practice. … 2005 191 인용
Alimentary pharmacology & … 2003 179 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
600-800 IU/day (RDA)
ibdsupport:
1,000-4,000 IU/day (target serum 25(OH)D >30 ng/mL)
deficiencycorrection:
50,000 IU/week for 8 weeks, then 1,000-4,000 IU/day maintenance

상한량: 4,000 IU/day (100 mcg); higher doses under medical supervision only

연구에서 사용된 용량

용량 기간 효과 N
None -- Positive --
None -- Mixed --
None -- Positive --
None -- Neutral --
None -- Negative 193
None -- Mixed --
None 690 weeks Neutral 357656
None -- Positive 310

권장 복용 시간: With a meal containing fat for better absorption

Safety & Side Effects

보고된 부작용

  • Hypercalcemia at very high doses (nausea, vomiting, weakness, confusion)
  • Kidney stones with excessive long-term supplementation
  • Constipation
  • Metallic taste

알려진 상호작용

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)
  • Statins (vitamin D may affect statin metabolism)

일일 최대 섭취 허용량: 4,000 IU/day (100 mcg); higher doses under medical supervision only

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Vitamin D help with Inflammatory Bowel Disease (IBD) — General?
Based on 10 studies with 1,500 participants, there is moderate evidence from clinical studies that Vitamin D may support Inflammatory Bowel Disease (IBD) — General management. Our evidence grade is B (Good Evidence).
How much Vitamin D should I take for Inflammatory Bowel Disease (IBD) — General?
Studies have used various dosages. A commonly studied range is 600-800 IU/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness, confusion), Kidney stones with excessive long-term supplementation, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Inflammatory Bowel Disease (IBD) — General?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 1,500 total participants. The overall direction of effect is positive.

Related Evidence

관련 다른 성분: Inflammatory Bowel Disease (IBD) — General

Vitamin D 다른 건강 상태에 대한 근거

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.